Neurogenesis
1 known investors
NeuroGenesis is a clinical-stage cellular therapy company developing the NG CELL platform, which uses a patient's own enhanced bone marrow stem cells to produce remyelinating and neuroprotective proteins delivered into the spinal cord fluid. It targets central nervous system diseases such as progressive multiple sclerosis and amyotrophic lateral sclerosis (ALS).
Founders & leadership
DH
Dorit HaratiRegulatory & Quality Assurance
MF
Mark FreedmanNeurologist / Neuroimmunology Scientist
DN
Dr. NetzerVP CMC and Operations
DK
Dr. KassisSenior Scientist
DK
Dr. KarussisDirector, MS Center and Neuroimmunology
T
TalCEO
Investors · 1
Frequently asked questions
- What does Neurogenesis do?
- NeuroGenesis is a clinical-stage cellular therapy company developing the NG CELL platform, which uses a patient's own enhanced bone marrow stem cells to produce remyelinating and neuroprotective proteins delivered into the spinal cord fluid. It targets central nervous system diseases such as progressive multiple sclerosis and amyotrophic lateral sclerosis (ALS).
- Who are Neurogenesis's investors?
- Neurogenesis's investors include Rhodium.